CALLIDITAS THERAPEUTICS ABCALLIDITAS THERAPEUTICS ABCALLIDITAS THERAPEUTICS AB

CALLIDITAS THERAPEUTICS AB

No trades
See on Supercharts

Price target

223.570.00 0.00%
The 11 analysts offering 1 year price forecasts for CALTX have a max estimate of — and a min estimate of —.

Analyst rating

Based on 10 analysts giving stock ratings to CALTX in the past 3 months.

EPS

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise

Revenue

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise
Be warned

Frequently Asked Questions

CALTX EPS for the last quarter is −0.34 SEK despite the estimation of −0.94 SEK. In the next quarter EPS is expected to reach −0.83 SEK. Track more of CALLIDITAS THERAPEUTICS AB financials and stay on top of what is up with the company.
In the next quarter CALLIDITAS THERAPEUTICS AB revenue is expected to reach ‪382.50 M‬ SEK. Check out CALLIDITAS THERAPEUTICS AB revenue and earnings and make informed decisions.
According to analysts, CALTX price target is 223.57 SEK with a max estimate of 300.12 SEK and a min estimate of 89.91 SEK. Check if this forecast comes true in a year, meanwhile keep track of the current situation with CALTX news and stock market news.
We've gathered opinions of 10 analysts rating CALTX stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as strong buy. Note that it's not a trading advice — your own analysis is still required.